Zenas Biopharma (ZBIO) Expected to Announce Quarterly Earnings on Tuesday

Zenas Biopharma (NASDAQ:ZBIO) is expected to be releasing its earnings data before the market opens on Tuesday, March 25th. Analysts expect Zenas Biopharma to post earnings of ($0.92) per share for the quarter.

Zenas Biopharma Stock Performance

ZBIO stock opened at $8.25 on Thursday. The firm has a market capitalization of $344.84 million and a PE ratio of -2.32. Zenas Biopharma has a twelve month low of $5.83 and a twelve month high of $26.25.

Wall Street Analysts Forecast Growth

ZBIO has been the topic of several research analyst reports. Wedbush initiated coverage on Zenas Biopharma in a research note on Thursday. They set an “outperform” rating and a $35.00 price objective on the stock. Guggenheim reaffirmed a “buy” rating and set a $45.00 price objective on shares of Zenas Biopharma in a research note on Wednesday, March 12th.

Zenas Biopharma Company Profile

Zenas BioPharma, Inc is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.